Influence of the COVID-19 Pandemic on Dutch Surgical Patterns of Care

NCT05126498 | Completed

• 1 other identifier: COVIDsurgII01
• Study Type: observational
• Target: 40,296
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to determine the impact of the COVID-19 pandemic on the Dutch surgical care, expressed as number of performed procedures, altered treatment plans, and surgical outcomes in the Netherlands during the year 2020.

Conditions

COVID-19

Keywords

surgery; COVID-19

Outcome Measures

Primary Outcomes (1)

• Number of performed surgical procedures

  The data on surgical outcomes was collected through the database of the Dutch Institute for Clinical Auditing

  2018-2020

Secondary Outcomes (6)

• Length of hospital stay (days)

  2018-2020

• 30-day hospital readmissions (percentage)

  2018-2020

• severe complications (Clavien-Dindo grade > 3A)

  2018-2020

• ICU admission (percentage)

  2018-2020

• length of ICU stay (days)

  2018-2020

Study Arms (3)

Cohort 2018

All surgically treated patients in the surgical audits for lung cancer surgery (DLCA-S), Upper gastrointestinal cancer surgery (DUCA), pancreatic cancer surgery (DPCA), hepatobiliary surgery (DHBA), colorectal cancer surgery (DCRA), hip fracture surgery (DHFA), aortic aneurysm surgery (DSAA), and bariatric surgery (DATO), from the participating hospitals in 2018

Other: no intervention

Cohort 2019

All surgically treated patients in the surgical audits for lung cancer surgery (DLCA-S), Upper gastrointestinal cancer surgery (DUCA), pancreatic cancer surgery (DPCA), hepatobiliary surgery (DHBA), colorectal cancer surgery (DCRA), hip fracture surgery (DHFA), aortic aneurysm surgery (DSAA), and bariatric surgery (DATO), from the participating hospitals in 2019

Other: no intervention

Cohort 2020

All surgically treated patients in the surgical audits for lung cancer surgery (DLCA-S), Upper gastrointestinal cancer surgery (DUCA), pancreatic cancer surgery (DPCA), hepatobiliary surgery (DHBA), colorectal cancer surgery (DCRA), hip fracture surgery (DHFA), aortic aneurysm surgery (DSAA), and bariatric surgery (DATO), from the participating hospitals in 2020

Other: no intervention

Interventions

no intervention OTHER

no intervention was applied

Cohort 2018; Cohort 2019; Cohort 2020

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

patients undergoing pulmonary, upper gastrointestinal, pancreatic, hepatobiliary, colorectal, hip fracture, aneurysm or bariatric surgery in one of the participating hospitals during the period January 1st 2018 until December 31st 2020.

You may qualify if:

• All patients who underwent pulmonary, upper gastrointestinal, pancreatic, hepatobiliary, colorectal, hip fracture, aneurysm or bariatric surgery
• Alle patients \>18 years
• Patients undergoing surgery during the period January 1st 2018 until December 31st 2020
• Hospital that performs the surgery has to participate in the study

You may not qualify if:

• none

Sponsors & Collaborators

• University Medical Center Groningen: lead

Study Sites (1)

UMCG

Groningen, 9700RB, Netherlands

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 16, 2021
• First Posted: November 19, 2021
• Study Start: August 1, 2020
• Primary Completion: May 1, 2021
• Study Completion: May 1, 2021
• Last Updated: April 16, 2024

Record last verified: 2024-04

Data Sharing

• IPD Sharing: Will not share

Locations

NL (1)